Stealing from the past: Globalisation, strategic formation and the use of indigenous intellectual property in the biotechnology industry (original) (raw)
Related papers
Lessons from the Interaction of Biotechnology, Intellectual Property and World Needs
Minnesota journal of law, science & technology, 2004
Intellectual property in agricultural biotechnology has spurred vigorous public debate over the global impact of advanced research in the life sciences. The University of Minnesota is not only a significant source of cutting-edge research, it is also a neutral forum for public debate. As the host of an April 29, 2004 conference, called “Intellectual Property Rights for the Public Good: Obligations of U.S. Universities to Developing Countries,” the University of Minnesota has taken the lead in examining the economic, societal, and ethical implications of its agricultural research.1 Resolving debates over intellectual property in agricultural technology is more than just a theoretical exercise. The ability to feed a growing population may rest on ensuring that the developing world receives and adopts new technology. Sharing that technology is a complex matter that involves social justice and academic ethics. My education in intellectual property and the development of genetic engineer...
REVIEW ARTICLE An international political economic view of the biotechnology industry
2016
This paper uses a model developed from the international political economy (IPE) school, to address the structure of the biotechnology industry. In particular, by focusing upon four primary structural elements of the industry, knowledge, production, finance and security with key secondary considerations of biosafety, public opinion and choice of intellectual property regime, the development of biotechnology companies from developed countries fits within a triad dominated industry with specific interests towards firms from developing countries. The activities of a sample of US National Association of securities Dealers Stock Market (NASDAQ) quoted biotechnology firms are investigated to support the model which concludes by the observation of the need to include both strategic and traditionally non strategic interests when reviewing policy formulation and objectives for firms in the biotechnology industry. A cursory reading of the public press on the biotechnology industry, presents a...
An international political economic view of the biotechnology industry
This paper uses a model developed from the international political economy (IPE) school, to address the structure of the biotechnology industry. In particular, by focusing upon four primary structural elements of the industry, knowledge, production, finance and security with key secondary considerations of biosafety, public opinion and choice of intellectual property regime, the development of biotechnology companies from developed countries fits within a triad dominated industry with specific interests towards firms from developing countries. The activities of a sample of US National Association of securities Dealers Stock Market (NASDAQ) quoted biotechnology firms are investigated to support the model which concludes by the observation of the need to include both strategic and traditionally non strategic interests when reviewing policy formulation and objectives for firms in the biotechnology industry.
In the twilight of the 20th century, Jeremy Rifkin's The Biotech Century (1998) 2 and Richard Oliver's The Biotech Age (2003) 3 expressed mixed feelings about the prospect of capital expansion through biotechnological innovation. The former was terrified while the latter was excited about this prospect. 4 Twelve years into the 21st century, the question that arises is, what is the actual relationship between the life sciences and the market? Rajan's collection of essays addresses this question by bringing together cultural anthropology and science and technology studies.
2003. ‘Globalisation and the governance of biotechnology’ Global Environmental Politics Vol.3 No.2.
This article examines the implications of the ways in which globalization processes interact with the international governance of agricultural biotechnology by assessing the inºuence of patterns of globalization upon four inter-related areas important to biotechnology governance: production; investment; regulation and political authority. This allows us to explore how changes in the production structures and patterns of investment by the biotechnology industry create the policy problems which existing governance structures have to manage. It also enables us to show how economic changes impact upon the scope and effectiveness of approaches to the regulation of crop biotechnologies, and the capacity of governments and international organizations to confront these challenges.
Jama The Journal Of The American Medical …, 2007
The biotechnology industry has in recent years come under attack from an ethical point of view concerning its intellectual property rights and the non accessibility of life-saving products for many of the poor in less developed countries and developing countries. The industry has replied with economic and legal justifications for its actions. The result has been a communication gap between the industry on the one hand and low income nations critics on the other. This paper attempts to present and evaluate the arguments on many sides and suggests a possible way out of the current impasse. It attempts to determine the ethical responsibility of the biotechnology industry in making products available to the needy, while at the same time developing the parallel responsibilities of individuals, governments, and NGOs. It concludes with the suggestion that the industry develop an international code for its self-regulation.